0 results available. Select is focused ,type to refine list, press Down to open the menu,
Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. It offers RYTELO a telomerase inhibitor for the treatment f adult pat...
The following section summarizes insights on Geron Corporation's Basic EPS Growth:
We've identified the following companies as similar to Geron Corporation because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Basic EPS Growth in the growth category include:
Period over prior period growth in basic eps.
The basic eps incl extra items growth measures a company’s basic eps incl extra items year-over-year growth. The formula to calculate basic eps growth and an example calculation for Geron’s trailing twelve months is outlined below:
Basic EPS Growth = (Current Year - Prior Year) / ABS(Prior Year Basic EPS Incl Extra Items)*
16.3% = (-$270.221 T - -$322.664 T) / $322.664 T
*ABS = An absolute value adjustment is used to ensure the direction of growth of negative numbers is reflected
The tables below summarizes Geron’s performance over the last five years:
| Fiscal Year | Basic EPS Incl Extra Items | Growth |
|---|---|---|
| 2020-12-31 | -0.28 | 22.7% |
| 2021-12-31 | -0.35 | −27.2% |
| 2022-12-31 | -0.37 | −5.2% |
| 2023-12-31 | -0.32 | 13.4% |
| 2024-12-31 | -0.27 | 16.3% |
The tables below summarizes Geron’s performance over the last four quarters:
| Quarter Ending | Basic EPS Incl Extra Items | Growth |
|---|---|---|
| 2024-03-31 | -0.092 | −31.1% |
| 2024-06-30 | -0.10 | −14.6% |
| 2024-09-30 | -0.040 | 48.3% |
| 2024-12-31 | -0.038 | 56.3% |
Growth calculations are always made in the company’s reporting currency to ensure currency fluctuations do not impact the calculation. Geron’s reports in the USD currency. You can read more about Basic EPS Incl Extra Items here.
The chart above depicts the distribution of basic eps growth for companies operating in the Healthcare sector in the Developed economic region. Over 2,410 companies were considered in this analysis, and 2,322 had meaningful values. The average basic eps growth of companies in the sector is 7.8% with a standard deviation of 111.4%.
Geron Corporation's Basic EPS Growth of 16.3% ranks in the 45.0% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,418 |
| Included Constituents | 2,322 |
| Min | -720.7% |
| Max | 389.8% |
| Median | 23.7% |
| Mean | 7.8% |
| Standard Deviation | 111.4% |
You can find companies with similar basic eps growth using this stock screener.